Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. scores highest on Torque (98) and lowest on Price (43). Its PosiPenta is 68.90 out of 100, better than most similar companies.
On the Penta Grid this week, Ironwood Pharmaceuticals, Inc. is Grid #23 of 837 in the Healthcare sector in United States, and Grid #61 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. | 68.90 | 43 | 79 | 66 | 98 | 60 |
| MiMedx Group, Inc. | 55.55 | 27 | 84 | 56 | 66 | 46 |
| ProKidney Corp. | 35.77 | 0 | 40 | 27 | 57 | 54 |
| Electra Therapeutics, Inc. | 35.43 | 0 | 26 | 41 | 68 | 42 |
| Phathom Pharmaceuticals, Inc. | 49.53 | 0 | 66 | 30 | 95 | 58 |
| Puma Biotechnology, Inc. | 64.40 | 50 | 47 | 93 | 77 | 55 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 4.55 |
| P/B ratio | -3.57 |
EEarnings
| Trailing EPS | ₹72.93 |
| Forward EPS | ₹142.07 |
NNitro
| Price | 331.50 |
| 52-week high | 547.45 |
| 52-week low | 135.44 |
| Fall from 52-week high | 39.4% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -2.28 |
AAnchor
| Beta (price swings) | 0.22 |
| Market cap | ₹5,477 Cr |
| Insider holding | 3.24% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Ironwood Pharmaceuticals, Inc.'s PosiPenta score?
Ironwood Pharmaceuticals, Inc.'s PosiPenta is 68.90 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Ironwood Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Ironwood Pharmaceuticals, Inc. is Grid #23 of 837 in the Healthcare sector in United States, and Grid #61 of 4,000 in United States.
Which PosiPenta pillar is strongest for Ironwood Pharmaceuticals, Inc.?
Torque (durability), with a score of 98 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Ironwood Pharmaceuticals, Inc.?
Price (valuation), with a score of 43 out of 100: around the middle of similar companies.
Has Ironwood Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.95 points, from 66.95 to 68.90.
PositoAI is for research and education only and is not investment advice.